Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -496.8% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 13.4 | n/a |
Pr/Book | 12.7 |
Latest | F'cast | |
---|---|---|
Revenue | 32.7% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-19 | n/a | (0.63) | (0.54)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-20 | 0.09 | (1.85) | (1.27)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | 0.83 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Suspension of CEO | 22-Apr-2024 | 07:00 | RNS |
Receipt of Requisition Letter | 17-Apr-2024 | 15:18 | RNS |
Holding(s) in Company | 16-Apr-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 2.20p |
Change Today | 0.20p |
% Change | 10.00 % |
52 Week High | 2.50 |
52 Week Low | 1.90 |
Volume | 5,896,069 |
Shares Issued | 506.29m |
Market Cap | £11.14m |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
17:08 | 25,000 @ 2.20p |
16:40 | 10,000 @ 2.20p |
16:40 | 1 @ 2.20p |
16:40 | 9,999 @ 2.20p |
16:23 | 27,296 @ 2.16p |
You are here: research